| FIRST AUTHOR INDEX |
| First Name |
Middle Name |
Last Name |
No. |
Title |
| Joseph |
|
R.Joseph |
SL |
Recognition, Treatment, Morbidity and Mortality in Bipolar Disorder |
| TOMIKI |
|
SUMIYOSHI |
JS5-2 |
Cognitive impairment in mood disorders; its assessment and therapeutics |
| TADAFUMI | | KATO |
S8-1
| Phenotypic discordance of iPS cells-derived neurons/cerebral organoids between monozygotic twins discordant for schizoaffective bipolar disorder |
| HARUHISA | | INOUE |
S8-4
| Disease modeling and drug discovery using iPSC platform |
| KAZUHIRO | | HAYASHI |
S20-2
| Game change of scholarly communication enhanced by Open Science and its policy |
| TOSHIAKI | | FURUKAWA |
PJ1
| Comparative efficacy and acceptability of 21 antidepressantdrugs for the acute treatment of adults with major depressive disorder: a systematic reviewand network meta-analysis |
| SAKI | | HATTORI |
EN2
| Effects of four atypical antipsychotics on autonomic nervous system activity in schizophrenia |
| KENTARO | | ONIKI |
EN3
| Association between oxidative stress-related genes polymorphisms and metabolic abnormalities among schizophrenia patients |
| Shitij | | Kapur |
LS1-3
| Dopamine and Antipsychotics:Past, Present and Future |
| Joseph | | R.Calabrese |
LS2-1
| Early Intervention in the Diagnosis and Treatment of Bipolar Disorder and Schizophrenia |
| Mark | | Zimmerman |
SS2-1
| Things That You Think You Know That May Not Be True in the Diagnosis and Treatment of Depression |
| KAZUNARI | | YOSHIDA |
O2-3
| A preliminary multi-genic prediction model for antipsychotic-induced weight gain |
| RYOSUKE | | ARAKAWA |
O3-1
| Norepinephrine transporter occupancy of venlafaxine extended-release in patients with major depressive disorder using positron emission tomography and radioligand [18F]FMeNER-D2 |
| TAKASHI | | OHNISHI |
O5-1
| Disrupted structural connectivity and less efficient network brain in the schizophrenia revealed by graph theoretical analysis |
| GENTARO | | MIURA |
O6-2
| Hospitalization-preventing effect of Long-Acting Injectable Versus Oral AntipsychoticsA Retrospective Bidirectional-Mirror-Image Study in Japanese Psychiatric Hospitals |
| YUYA | | MIZUNO |
O7-4
| Heterogeneity of antipsychotic efficacy in treatment resistant schizophrenia: A meta-analysis |
| FUMIHIKO | | UENO |
O9-2
| Influence of Alcohol and Acetaldehyde on Human Psychomotor Functions: Findings from the Alcohol Clamping in Healthy Young Population |
| MAKOTO | | ISHITOBI |
O10-2
| Paroxysmal kinesigenic dyskinesia associated with depression in a bipolar patient with comorbid idiopathic basal ganglia calcification |
| KAOSU | | MATSUMORI |
O11-2
| A Computational Psychiatric Model with Exponentially Biased Bayesian Inference for Mental Diseases |
| KAZUTAKA | | OHI |
O12-2
| Genome-wide variants shared between smoking quantity and schizophrenia on 15q25 are associated with CHRNA5 expression in the brain |
| Marco | | Riva |
O12-3
| Anti-stress and neuroplastic effects of blonanserin in preclinical models |
| YOKI | | NAKAMURA |
O13-2
| Sigma-1 receptor plays a key role in the control of extracellular vesicle release by modulating the activity of the ADP-Ribosylation Factor 6 at the mitochondrion-endoplasmic reticulum interface |
| SHINICHIRO | | NAKAJIMA |
O14-1
| Glutamatergic Neurometabolite Levels in Major Depressive Disorder: A Systematic Review and Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies |
| TAKUMA | | INAGAWA |
P1-4
| A meta-analysis of the effects of multi-session transcranial direct current stimulation on cognition in dementia and mild cognitive impairment. |
| TAKASHI | | OHNISHI |
P3-2
| The large scale disturbed white matter fibre in schizophrenia revealed by local connectometry |
| YUZURU | | KATAOKA |
P4-4
| Difference in executive function among with patients with schizophrenia, their first degree relatives and healthy subjects |
| YUSUKE | | IWATA |
P6-1
| Glutamatergic Neurometabolite Levels in Patients with Ultra Treatment-Resistant Schizophrenia: a Cross-sectional 3T Proton MRS study |
| KEN | | INADA |
P6-5
| Analysis of clozapine use and safety using comprehensive national data from the Japanese Clozapine Patient Monitoring Service |
| SHIN | | KUROSE |
P7-1
| Time Courses of Central Dopamine D2 Receptor Occupancy and Peripheral Blood Concentrations of Antipsychotics: A Systematic Review |
| SAKI | | HATTORI |
P9-5
| Associations of ABCB1 gene polymorphisms with aripiprazole-induced autonomic nervous system dysfunction in schizophrenia |
| KYOSUKE | | SAWADA |
P14-1
| Impact of subjective vs. objective remission status on subjective cognitive impairments in depression |
| Cynthia | | Siu |
P19-1
| NETWORK MODEL OF DEPRESSIVE AND MANIC SYMPTOMS IN THE STEP-BD STUDY |
| TOSHINORI | | SHIRATA | P27-6
| Relationship of high neuroticism with increased methylation of the BDNF gene in healthy subjects |
